![Mette Husbyn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mette Husbyn
Directeur Technique/Scientifique/R&D chez
LYTIX BIOPHARMA ASA
Profil
Mette Husbyn currently works at Lytix Biopharma AS, as Chief Technical Officer from 2025.
Dr. Husbyn also formerly worked at Lytix Biopharma AS, as Head-CMC from 2012 to 2017 and Nykode Therapeutics ASA, as Chief Technical Officer & Head-CMC from 2017 to 2025.
Dr. Husbyn received her doctorate degree in 2003 from the University of Oslo.
Postes actifs de Mette Husbyn
| Sociétés | Poste | Début |
|---|---|---|
| LYTIX BIOPHARMA ASA | Directeur Technique/Scientifique/R&D | 01/02/2025 |
Anciens postes connus de Mette Husbyn
| Sociétés | Poste | Fin |
|---|---|---|
| NYKODE THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/01/2025 |
| LYTIX BIOPHARMA ASA | Corporate Officer/Principal | 01/01/2017 |
Formation de Mette Husbyn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
